Literature DB >> 14566824

Freshly isolated bone marrow cells induce death of various carcinoma cell lines.

Nicolas Larmonier1, François Ghiringhelli, Claire B Larmonier, Monique Moutet, Annie Fromentin, Emmanuel Baulot, Eric Solary, Bernard Bonnotte, François Martin.   

Abstract

In some carcinomas such as digestive tract carcinomas, bone marrow infiltration by tumor cells is a frequent event but usually remains a micrometastatic disease and rarely induces overt bone lesions. The mechanisms responsible for the control of these metastases in the bone marrow remain poorly known. We show that freshly isolated bone marrow cells from human, murine and rat origin rapidly kill a wide range of syngeneic or xenogeneic carcinoma cell lines in culture. Further analysis of this cytotoxic process in the rat indicated that neither resident bone marrow macrophages nor NK cells were responsible for this cytotoxic effect that was restricted to a subpopulation of bone marrow cells expressing CD90 (Thy-1), a marker of hemopoietic precursors. The tumoricidal activity of these cells did not require long-term culture nor addition of exogenous cytokines or growth factors. A subset of CD90+ cells that rapidly differentiates into CD163(ED2)-expressing macrophages was observed to be responsible for tumor cell killing. These macrophages induced a non-apoptotic death of tumor cells, a process that required both a direct interaction with the tumor cell and nitric oxide (NO) production through the activation of inducible nitric oxide-synthase (iNOS). This ability of pluripotent hemopoietic stem cells to rapidly differentiate into macrophages capable of killing invasive tumor cells may account for the limited expansion of micrometastases of some carcinomas in the bone marrow. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566824     DOI: 10.1002/ijc.11463

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice.

Authors:  Chiyo Doi; Dharmendra Kumar Maurya; Marla M Pyle; Deryl Troyer; Masaaki Tamura
Journal:  Cytotherapy       Date:  2010-05       Impact factor: 5.414

2.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

3.  Identification and characterization of unique tumoricidal genes in rat umbilical cord matrix stem cells.

Authors:  Deepthi Uppalapati; Naomi Ohta; Yongqing Zhang; Atsushi Kawabata; Marla M Pyle; Kevin G Becker; Deryl Troyer; Masaaki Tamura
Journal:  Mol Pharm       Date:  2011-09-13       Impact factor: 4.939

4.  Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo.

Authors:  Rie Ayuzawa; Chiyo Doi; Raja Shekar Rachakatla; Marla M Pyle; Dharmendra Kumar Maurya; Deryl Troyer; Masaaki Tamura
Journal:  Cancer Lett       Date:  2009-03-13       Impact factor: 8.679

5.  Lymph node micrometastases are associated with disease recurrence and poor survival for early-stage non-small cell lung cancer patients: a meta-analysis.

Authors:  Xu Feng Deng; Li Jiang; Quan Xing Liu; Dong Zhou; Bing Hou; Kefan Cui; Jia Xin Min; Ji Gang Dai
Journal:  J Cardiothorac Surg       Date:  2016-02-16       Impact factor: 1.637

6.  Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer.

Authors:  Erika Heninger; Nan Sethakorn; David Kosoff; Peiman Hematti; Morgan D Kuczler; Kenneth J Pienta; Joshua M Lang
Journal:  Oncotarget       Date:  2020-11-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.